April 27, 2015
The Pharmaceutical Affairs and Food Sanitation Council’s Second Committee on Drugs, an advisory organ to the health minister, on April 24 supported approval of MSD’s PegIntron (recombinant peginterferon alfa-2b) for use as an adjuvant therapy for malignant melanoma. With malignant...read more